Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

HOXB7 is an ERα cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance.

Jin K, Park S, Teo WW, Korangath P, Cho SS, Yoshida T, Gyorffy B, Goswami CP, Nakshatri H, Cruz LA, Zhou W, Ji H, Su Y, Ekram M, Wu Z, Zhu T, Polyak K, Sukumar S.

Cancer Discov. 2015 Jul 15. pii: CD-15-0090. [Epub ahead of print]

PMID:
26180042
2.

TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.

Perkins SM, Bales C, Vladislav T, Althouse S, Miller KD, Sandusky G, Badve S, Nakshatri H.

Breast Cancer Res Treat. 2015 Jul 10. [Epub ahead of print]

PMID:
26160249
3.

Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells.

Burnett RM, Craven KE, Krishnamurthy P, Goswami CP, Badve S, Crooks P, Mathews WP, Bhat-Nakshatri P, Nakshatri H.

Oncotarget. 2015 May 20;6(14):12682-96.

4.

NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.

Nakshatri H, Appaiah HN, Anjanappa M, Gilley D, Tanaka H, Badve S, Crooks PA, Mathews W, Sweeney C, Bhat-Nakshatri P.

Cell Death Dis. 2015 Jan 22;6:e1608. doi: 10.1038/cddis.2014.569.

PMID:
25611383
5.

PROGgeneV2: enhancements on the existing database.

Goswami CP, Nakshatri H.

BMC Cancer. 2014 Dec 17;14:970. doi: 10.1186/1471-2407-14-970.

6.

Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle.

Chen D, Goswami CP, Burnett RM, Anjanappa M, Bhat-Nakshatri P, Muller W, Nakshatri H.

Cancer Res. 2014 Aug 15;74(16):4270-81. doi: 10.1158/0008-5472.CAN-13-2817. Epub 2014 Jun 30.

PMID:
24980554
7.

The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes.

Loganathan J, Jiang J, Smith A, Jedinak A, Thyagarajan-Sahu A, Sandusky GE, Nakshatri H, Sliva D.

Int J Oncol. 2014 Jun;44(6):2009-15. doi: 10.3892/ijo.2014.2375. Epub 2014 Apr 9.

PMID:
24718855
8.

Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain.

Avraham HK, Jiang S, Fu Y, Nakshatri H, Ovadia H, Avraham S.

J Pathol. 2014 Feb;232(3):369-81. doi: 10.1002/path.4304.

PMID:
24421076
9.

PROGgene: gene expression based survival analysis web application for multiple cancers.

Goswami CP, Nakshatri H.

J Clin Bioinforma. 2013 Oct 28;3(1):22. doi: 10.1186/2043-9113-3-22.

10.

Identification of FDA-approved drugs targeting breast cancer stem cells along with biomarkers of sensitivity.

Bhat-Nakshatri P, Goswami CP, Badve S, Sledge GW Jr, Nakshatri H.

Sci Rep. 2013;3:2530. doi: 10.1038/srep02530.

11.

ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.

Chen D, Bhat-Nakshatri P, Goswami C, Badve S, Nakshatri H.

Cancer Res. 2013 Sep 15;73(18):5821-33. doi: 10.1158/0008-5472.CAN-13-1080. Epub 2013 Jul 5.

12.

HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression.

Shah N, Jin K, Cruz LA, Park S, Sadik H, Cho S, Goswami CP, Nakshatri H, Gupta R, Chang HY, Zhang Z, Cimino-Mathews A, Cope L, Umbricht C, Sukumar S.

Cancer Res. 2013 Sep 1;73(17):5449-58. doi: 10.1158/0008-5472.CAN-13-1178. Epub 2013 Jul 5.

13.

Interplay between estrogen receptor and AKT in estradiol-induced alternative splicing.

Bhat-Nakshatri P, Song EK, Collins NR, Uversky VN, Dunker AK, O'Malley BW, Geistlinger TR, Carroll JS, Brown M, Nakshatri H.

BMC Med Genomics. 2013 Jun 11;6:21. doi: 10.1186/1755-8794-6-21.

14.

PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data.

Goswami CP, Nakshatri H.

J Clin Bioinforma. 2012 Dec 28;2(1):23. doi: 10.1186/2043-9113-2-23.

15.

Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse.

Choi MR, Bardhan R, Stanton-Maxey KJ, Badve S, Nakshatri H, Stantz KM, Cao N, Halas NJ, Clare SE.

Cancer Nanotechnol. 2012 Dec;3(1-6):47-54. Epub 2012 Jul 20.

16.

Role of AKT isotypes in breast cancer.

Badve S, Nakshatri H.

J Pathol. 2013 Feb;229(3):e1. doi: 10.1002/path.4137. No abstract available.

PMID:
23132205
17.

Breast-cancer stem cells-beyond semantics.

Badve S, Nakshatri H.

Lancet Oncol. 2012 Jan;13(1):e43-8. doi: 10.1016/S1470-2045(11)70191-7. Review.

PMID:
22225725
18.

Biomarkers for breast cancer stem cells: the challenges ahead.

Gökmen-Polar Y, Nakshatri H, Badve S.

Biomark Med. 2011 Oct;5(5):661-71. doi: 10.2217/bmm.11.57. Review.

PMID:
22003917
19.

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.

Appaiah HN, Goswami CP, Mina LA, Badve S, Sledge GW Jr, Liu Y, Nakshatri H.

Breast Cancer Res. 2011 Sep 13;13(5):R86. doi: 10.1186/bcr2943.

20.

Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasis.

Wang F, Li J, Sinn AL, Knabe WE, Khanna M, Jo I, Silver JM, Oh K, Li L, Sandusky GE, Sledge GW, Nakshatri H, Jones DR, Pollok KE, Meroueh SO.

J Med Chem. 2011 Oct 27;54(20):7193-205. doi: 10.1021/jm200782y. Epub 2011 Oct 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk